Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
FOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot…
Failed Dissolution Specifications
CGMP Deviations:Noted during FDA inspection
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
CGMP Deviations:Noted during FDA inspection
CGMP Deviations:Noted during FDA inspection
CGMP Deviations:Noted during FDA inspection
Failed content uniformity specifications.
CGMP Deviations:Noted during FDA inspection
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Lack of assurance of sterility.
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Discolored solution.